Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CIRRUS LOGIC, INC. Director's Dealing 2016

Nov 14, 2016

30880_dirs_2016-11-14_e0aacaf3-0078-4b28-83bd-99c175d30292.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CIRRUS LOGIC INC (CRUS)
CIK: 0000772406
Period of Report: 2016-11-10

Reporting Person: Rhode Jason P (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-10 Common Stock M 8211.0 $23.34 Acquired 155306 Direct
2016-11-10 Common Stock M 6153.0 $16.25 Acquired 161459 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-11-10 Incentive Stock Option (right to buy) $16.25 M 6153.0 Disposed 2020-10-06 Common Stock (6153) Direct
2016-11-10 Incentive Stock Option (right to buy) $23.34 M 8211.0 Disposed 2023-10-02 Common Stock (8211) Direct

Footnotes

F1: Dr. Rhode continues to beneficially own 690,326 shares, which includes 528,867 shares issuable upon exercise of vested stock options held by Dr. Rhode and 161,459 shares held directly.

F2: The option vested on a 4-year schedule: 25% of the shares became exercisable on 10/6/2011; the remaining 75% of the shares vested at a rate of 1/36th per month over the following 36 months so that the option was fully vested and exercisable on 10/6/2014. Only vested shares can be exercised under this option.

F3: The option vests on a 4-year schedule: 25% of the shares became exercisable on 10/2/2014; the remaining 75% of the shares vest at a rate of 1/36th per month over the following 36 months so that the option will be fully vested and exercisable on 10/2/2017. Only vested shares can be exercised under this option.